Quick Summary of Astellas Pharma Inc. ver.2017

SKU:
$240.00
$240.00
Unavailable
per item
This report is good for a company/person who want to quickly learn about keys for Astellas, especially in the clinical related fields.

  • Company Overview
  • Financial Summary
  • Main Therapeutic Area
  • Key Products
  • Pipeline
  • Organization
  • Updated news

Astellas Pharma is one of the largest prescription drug companies in Japan. The company's main products include organ transplant immunosuppressant Prograf, overactive bladder treatment Vesicare, hypertension therapy Micardis, prostate enlargement treatment Harnal, and cholesterol drug Lipitor. 

With “VISION 2015”, Astellas aims to become a Global Category Leader (GCL) in several therapeutic areas, and has been implementing various strategic actions. Those include further globalization and rationalization in its organization and processes.